Respiratory Syncytial Virus Infection
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: A Study to Learn About ABRYSVO Vaccine in Older Adults to Prevent Severe Respiratory Syncytial Virus (RSV) Disease
Pfizer is conducting a study to evaluate ABRYSVO for preventing severe respiratory syncytial virus infection in older adults, with the trial…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Phase II Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 50 Years or Above [Phase 2]
Phase II clinical trial update for a lyophilized mRNA vaccine targeting respiratory syncytial virus in adults aged 50 years or older. The st…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Phase I Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 18 Years or Above [Phase 1]
This entry updates a Phase 1 clinical trial of a lyophilized mRNA vaccine for respiratory syncytial virus in adults; the study is currently …
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: A Study of BLB-201 RSV Vaccine in Infants and Children [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating BLB-201 RSV vaccine in infants and children is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons [Phase 2]
A Phase 2 clinical trial is evaluating the immunogenicity of the RSVPreF3 vaccine in immunocompromised adults, with recruitment ongoing.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-12-12EMA Authorised: Synagis (palivizumab) — AstraZeneca AB
The EMA authorised Synagis (palivizumab) for respiratory syncytial virus infections, with AstraZeneca AB as the marketing authorisation hold…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Effectiveness of Immunization in Preventing Severe Acute Respiratory Infection RSV
A clinical trial is evaluating the effectiveness of an immunization to prevent severe acute respiratory infections caused by Respiratory Syn…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older [Phase 1, Phase 2]
Phase 1/2 study of Sanofi Pasteur's lipid nanoparticle-encapsulated mRNA vaccine candidate for human metapneumovirus and respiratory syncyti…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies
Clinical trial update on a next-generation non-invasive passive detection technology for COVID-19/SARS-CoV-2, with the study currently activ…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell) [Phase 3]
Phase III trial evaluating a recombinant Respiratory Syncytial Virus vaccine produced in CHO cells is currently recruiting. No results are r…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Promotion of RSV Immunization Through Multiple Efforts [Phase 3]
Phase 3 trial update from Washington University School of Medicine focusing on promoting RSV vaccination during pregnancy; the study status …
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Diagnosis and Treatment Status and Medical Burden of Respiratory Syncytial Virus Infection in Children in China
A ClinicalTrials.gov entry from Beijing Children's Hospital provides an update on the NCT07264478 study. It describes the study's active-not…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: A Post-marketing Surveillance Study of Beyfortus (Nirsevimab) in Republic of Korea
A post-marketing surveillance study in South Korea to monitor safety and real-world outcomes of Beyfortus (nirsevimab) for respiratory syncy…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: RSV Vaccine in Transplant Recipients [Phase 3]
Phase 3 trial evaluating an RSV vaccine in immunosuppressed transplant recipients is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools
The CARE-ID trial is currently recruiting to study dynamics of respiratory infections in children and transmission in households and schools…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: A Clinical Trial of SIBP-A16 Injection in Healthy Adults [EARLY_Phase 1]
This entry reports an early-phase 1 clinical trial of SIBP-A16 Injection in healthy adults, evaluating safety for potential use against resp…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults [Phase 4]
A Phase 4 clinical trial is evaluating the effectiveness of a bivalent RSV prefusion F protein-based vaccine to prevent RSV-related hospital…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months [Phase 1]
Clinical trial update describing safety, tolerability, and immunogenicity assessment of Moderna’s mRNA vaccines mRNA-1345 and mRNA-1365 in i…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years [Phase 1]
Phase 1 study evaluating the safety and immune response of an investigational vaccine for Respiratory syncytial virus infection and Human me…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Genotype and Disease Burden of RSV in Older Vietnamese Adults (RSV: Respiratory Syncytial Virus )
A clinical trial studying the genotype and disease burden of respiratory syncytial virus (RSV) in older adults in Vietnam. The study is curr…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)
An ongoing Pfizer-sponsored real-world study in Australia is evaluating how effective the maternal RSVpreF vaccine is at preventing respirat…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination [Phase 3]
A Phase 3 trial evaluating administering Nirsevimab to infants, with or without maternal RSV vaccination, to prevent RSV infection. The stud…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: A Study to Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) Infection [Phase 2, Phase 3]
Pfizer's Phase 2/3 study of sisunatovir in adults with Respiratory Syncytial Virus infection was terminated and results were posted in 2025.
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of RSVpreF Coadministered With Herpes Zoster Vaccine in Adults [Phase 3]
Phase 3 study evaluating the safety and immunogenicity of RSVpreF coadministered with the herpes zoster vaccine in adults has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: BEYFORTUS™ (Nirsevimab) Effectiveness Against Medically-Attended RSV Events in Infants (BEAR Study)
This clinical trial update reports on the BEAR study evaluating BEYFORTUS (nirsevimab) for preventing medically attended respiratory syncyti…